“ESAC, Inc. is pleased to announce the successful launch of the Proteomic Data Commons (PDC) within the National Cancer Institute’s (NCI) Cancer Research Data Commons (CRDC) on the cancer.gov domain on March 23, 2020.”
“According to ESAC Project Manager, Ratna Thangudu, Ph.D., ‘The PDC is a next-generation proteomic data repository within NCI’s CRDC that facilitates proteogenomics to revolutionize precision medicine.’”
“The PDC provides the largest collection of freely available cancer proteomic data on a highly scalable cloud-based infrastructure that facilitates bringing analysis tools to the data instead of the opposite. Whereas in the past, data sets have been analyzed with separate computational pipelines, the PDC harmonizes proteomic data with a common set of analytic pipelines to facilitate comparisons between different samples and cancer types.”
“The PDC makes it possible for any researcher to ask new and fundamental questions about cancer and provides much-needed tools to accelerate research and the development of personalized treatments for individual patients. Cancer researchers can now easily access the multi-omics (proteomic, genomic, imaging, etc..) data from many sources across the CRDC’s virtual, expandable infrastructure, thus lowering the entry barrier for anyone who wants to get involved in integrative research.”
“According to Michael Holck, Vice President of Software Engineering at ESAC, the PDC is hosted within the Amazon Web Services (AWS) cloud allowing for easy access anywhere in the world and provides extremely large scalability to accommodate large volumes of data and compute power for data analysis…” Read the full press release here.
Source: New Data Repository May Revolutionize Precision Medicine – April 6, 2020. ESAC.
